LU87952A1 - Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree - Google Patents

Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree Download PDF

Info

Publication number
LU87952A1
LU87952A1 LU87952A LU87952A LU87952A1 LU 87952 A1 LU87952 A1 LU 87952A1 LU 87952 A LU87952 A LU 87952A LU 87952 A LU87952 A LU 87952A LU 87952 A1 LU87952 A1 LU 87952A1
Authority
LU
Luxembourg
Prior art keywords
somatostatin
acid
formula
composition according
administration
Prior art date
Application number
LU87952A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87952A1 publication Critical patent/LU87952A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU87952A 1990-06-15 1991-06-13 Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree LU87952A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use

Publications (1)

Publication Number Publication Date
LU87952A1 true LU87952A1 (fr) 1993-01-15

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87952A LU87952A1 (fr) 1990-06-15 1991-06-13 Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree

Country Status (21)

Country Link
EP (1) EP0462071B1 (zh)
JP (1) JPH04230223A (zh)
KR (1) KR920000323A (zh)
AU (1) AU7833191A (zh)
CA (1) CA2044511A1 (zh)
CH (1) CH683069A5 (zh)
DE (1) DE4119062A1 (zh)
ES (1) ES2067906T3 (zh)
FI (1) FI912868A (zh)
FR (1) FR2663227B1 (zh)
GB (2) GB9013448D0 (zh)
HU (1) HUT59007A (zh)
IE (1) IE912010A1 (zh)
IL (1) IL98477A0 (zh)
IT (1) IT1297205B1 (zh)
LU (1) LU87952A1 (zh)
NO (1) NO912271L (zh)
NZ (1) NZ238522A (zh)
PT (1) PT97964A (zh)
TW (1) TW226332B (zh)
ZA (1) ZA914583B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
KR100327563B1 (ko) * 1993-07-30 2002-08-24 데이진 가부시키가이샤 펩티드단백질성약물경기분제조성물
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
PL357674A1 (en) * 2000-04-19 2004-07-26 Thomas Julius Borody Compositions and therapies for hyperlipidaemia-associated disorders
US20030083241A1 (en) * 2001-11-01 2003-05-01 Young Charles W. Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
SI2275103T1 (sl) 2005-11-21 2014-07-31 Novartis Ag mTor inhibitorji pri zdravljenju endokrinih tumorjev
EP1959982B1 (en) * 2005-12-01 2012-08-08 Flinders Technologies PTY. Ltd. Methods and compositions for preventing and/or treating pancreatitis
BRPI0918652B1 (pt) 2008-09-17 2021-10-19 Chiasma, Inc. Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Also Published As

Publication number Publication date
GB9013448D0 (en) 1990-08-08
ZA914583B (en) 1993-02-24
KR920000323A (ko) 1992-01-29
HUT59007A (en) 1992-04-28
ITRM910430A0 (it) 1991-06-17
FI912868A0 (fi) 1991-06-13
NZ238522A (en) 1993-10-26
IE912010A1 (en) 1991-12-18
JPH04230223A (ja) 1992-08-19
IL98477A0 (en) 1992-07-15
GB9112509D0 (en) 1991-07-31
DE4119062A1 (de) 1991-12-19
NO912271L (no) 1991-12-16
CH683069A5 (de) 1994-01-14
EP0462071A1 (en) 1991-12-18
PT97964A (pt) 1992-03-31
EP0462071B1 (en) 1995-02-01
GB2244918A (en) 1991-12-18
IT1297205B1 (it) 1999-08-03
ES2067906T3 (es) 1995-04-01
ITRM910430A1 (it) 1992-12-17
FR2663227B1 (fr) 1995-04-28
FR2663227A1 (fr) 1991-12-20
TW226332B (zh) 1994-07-11
HU911849D0 (en) 1991-12-30
AU7833191A (en) 1992-01-02
GB2244918B (en) 1994-06-15
FI912868A (fi) 1991-12-16
CA2044511A1 (en) 1991-12-16
NO912271D0 (no) 1991-06-13

Similar Documents

Publication Publication Date Title
EP3275460A1 (en) Methods and compositions for oral administration of exenatide
LU87952A1 (fr) Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
CA2709899C (fr) Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
BE1003817A3 (fr) Sels d'addition d'acides de derives n-acyles de la taurine ou de la glycine, leur preparation et leur utilisation.
LU86901A1 (fr) Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
BE1004038A4 (fr) Nouvelle utilisation therapeutique d'analogues ou de derives de la somatostatine.
EP0099766B1 (fr) Nouveaux dérivés de la 1,3-dihydro 4-(1-hydroxy 2-aminoéthyl) 2H-indol-2-one, leurs sels, procédé de préparation, application à titre de médicaments et compositions les renfermant
EP0255415B1 (fr) Utilisation de phényléthanolamines pour la préparation de médicaments agissant sur les troubles gastro-intestinaux
BE1004645A3 (fr) Nouvelle utilisation therapeutique de peptides derives de la somatostatine.
EP4210680A1 (en) Improved pharmaceutical formulations of glp-1 receptor agonists
FR2510112A1 (fr) Nouveaux derives du 2-oxo-pyrid-3-yl ou piperidin-3-yl indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2668933A1 (fr) Composition pharmaceutique a base de somatostatine.
BE1003762A3 (fr) Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives.
JP2008001690A (ja) Ｇタンパク質共役型レセプターの作動剤および医薬
FR2623090A1 (fr) Compositions pharmaceutiques contenant une calcitonine
BE1003200A4 (fr) Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments.
EP0750635B1 (fr) Peptides pour inhiber la liberation de pepsine
BE839405A (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
EP4301399A1 (fr) Composition pharmaceutique pour une administration par voie orale d'un agoniste du recepteur du glp-1
JPH0138771B2 (zh)
JPH0320400B2 (zh)
FR2464942A1 (fr) Polypeptide, procede pour son isolement, et ses utilisations therapeutiques
BE821742A (fr) Amides a activite biologique
BE839828A (fr) Undecapeptides cycliques analogues de la somatostatine et leur preparation